CREB was well‐known as a nuclear transcription factor playing a key role in the breast cancer bone metastasis, but strategies targeting CREB signalling pathway such as kinase inhibitors or CREB‐CRE interaction inhibitors might elicit many off‐target effects. Here, CREB1 is linked to breast carcinoma.